Growth Capital • Medical Products

Borromin Capital Management Invests In W.Söhngen

On June 1, 2019, private equity firm Borromin Capital Management invested in medical products company W.Söhngen

Investment Context
  • This is Borromin Capital Management’s 1st transaction in the Medical Products sector.
  • This is Borromin Capital Management’s 18th transaction in Germany.

Explore All 336 Growth Capital Medical Products Deals - Search the Database Free


Investment Summary

Date June 1, 2019
Target W.Söhngen
Sector Medical Products
Investor(s) Borromin Capital Management
Deal Type Growth Capital

Target Company

W.Söhngen

Taunusstein, Germany
W.Söhngen is a wholesaler for dressings for pharmacies, drugstores, and medical supply stores and manufacturers and suppliers of high-quality products for wound care, first aid, and emergency medicine. With a portfolio of more than 14,000 articles, Söhngen offers its customers both standardized and individualized solutions. Extensive know-how, innovative developments, and the ability to think and act in a market-oriented manner have made Söhngen a leading provider of first aid and emergency medicine products in Europe. W.Söhngen was founded in 1923 and is based in Taunusstein, Germany.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

Borromin Capital Management

Frankfurt am Main, Germany

Investor Investor


Category Private Equity Firm
Founded 2001
PE ASSETS 626M EUR
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Borromin Capital Management GmbH is a private equity firm specializing in management buyouts, spin-offs of mid-sized companies located throughout German-speaking Europe. Borromin Capital Management GmbH focuses on cash-flow positive companies with proven business models and strong market positions. Borromin Capital Management GmbH will not invest in turnaround situations. Borromin Capital Management GmbH was formerly known as BHF Private Equity GmbH. Borromin Capital Management GmbH was formed in 2001 and is based in Frankfurt.


Deal Context for Investor #
Overall 21 of 28
Sector: Medical Products 1 of 2
Type: Growth Capital 2 of 2
Country: Germany 18 of 24
Year: 2019 4 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-05-01 BUK Kunststofftechnik

Eppingen, Germany

BUK Kunststofftechnik (BUK Group) is a manufacturer of high precision and complex injection moulding parts for customers in diverse sectors. BUK Group specializes in the production of sophisticated technical plastic molded parts (individual parts and assemblies) based on the latest injection molding machines. The product range extends from high-precision plastic parts for small electrical devices (e.g. grinding tools) to complex assemblies for high-pressure pumps and ventilation and cooling devices. BUK supports its customers from the development of new products, through pre-series to serial production using customer-specific injection molding tools and state-of-the-art production processes. BUK Group comprises BUK Kunststofftechnik GmbH and EMG GmbH and UHB Kunststofftechnik GmbH. BUK Kunststofftechnik was founded in 1985 and is based in Eppingen, Germany.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-08-13 WATR Group

Bad Bentheim, Germany

WATR Group is a groundwater management and (ground-)water purification company encompassing dewatering and groundwater management services, mobile water purification, temporary pump installations, and related ground protection products. It operates Koop, Clausen, Ko-Mats, Buitenkamp, and BC-Envirotec. WATR Group was formed in 1969 and is based in Bad Bentheim, Germany.

Buy -